1. Buffalo, NY – June 05, 2017. With Another Phase III Trial, BNAC Solidifies Imaging Expertise. UB’s Buffalo Neuroimaging Analysis Center (BNAC) played a pivotal role in a phase III clinical trial of the first transcatheter cerebral embolic protection (TCEP) device to obtain marketing clearance by the Food and Drug Administration.
  2. Cambridge, MA – April 25, 2017. New Data Suggest Positive Effects of Sanofi Genzyme’s AubagioR (teriflunomide) on Cortical Gray Matter Atrophy.
  3. Basel, Switzerland – April 24, 2017. Novartis real-world data at AAN confirms benefit of Gilenya on four key measures of disease activity in relapsing MS.
  4. Buffalo, NY – June 30, 2016. Tracking brain atrophy in MS could become routine, thanks to software developed at UB. International UB study starting in July of 2016 aims to validate software to assess brain atrophy in more than 1,000 MS patients.
  5. Buffalo, NY – June 15, 2016. Study: Cerebral microbleeds in MS patients are associated with an Increased Risk for Physical and Cognitivies disabilities.
    Researchers in the Jacobs School of Medicine and Biomedical Sciences at UB are continuing to study cerebral microbleeds as indiciators of disease progression in Multiple Sclerosis.
  6. Buffalo, NY – September 29, 2015. In MS patients, HDL cholesterol has a protective effect. Findings from a new study could lead to new treatments for MS as well as lifestyle guidelines for preventing it.
  7. Buffalo, NY – January 22, 2015. Diet affects brain iron levels differently in men and women, UB pilot study shows.
  8. Buffalo, NY – April 17, 2014. . Special Delivery: 7-Ton MRI to Aid Groundbreaking Research at UB.
  9. Buffalo, NY – February 6, 2014. Research on venous abnormalities must continue, urge UB authors of one of neurology’s most cited papers.
  10. Buffalo, NY – January 9, 2014. Pro athlete study to assess early onset dementia, potential CTE.
  11. Buffalo, NY – November 25, 2013. Beyond the brain: vascular changes in the neck may play role in Alzheimer’s.
  12. Rijeka, Croatia – November 5, 2013. Dr. Robert Zivadinov, expert on multiple sclerosis, in Thalassotherapy, on scientific project.
  13. Buffalo, NY – July 9, 2013.
    UB’s Pediatric MS Center Shares in National Network Grant
  14. Buffalo, NY – July 1, 2013.
    UB’s new CTRC imaging center is Western New York’s first devoted exclusively to research
  15. Buffalo, NY – March 22, 2013.
    Multiple Sclerosis research: the thalamus moves into the spotlight
  16. Buffalo, NY – March 15, 2013.
    MS patients did not benefit from CCSVI intervention, landmark pilot study of ‘liberation treatment’ finds
  17. Buffalo, NY – March 11, 2013.
    Aerobic exercise promotes post-concussion healing, UB research finds
  18. Buffalo, NY – November 21, 2012.
    Before Canadian Senate, Zivadinov urges caution for CCSVI treatment
  19. Buffalo, NY – November 30, 2011.
    Risk factors for CCSVI are similar to risk factors for developing MS, UB study shows
  20. Buffalo, NY – April 14, 2011.
    Higher CCSVI prevalence confirmed in MS, but meaning of findings remains unclear
  21. Buffalo, NY – February 10, 2010.
    First Blinded Study of Venous Insufficiency Prevalence in MS Shows Promising Results
  22. Buffalo, NY – November 20, 2009.
    MS more aggressive in children but slower to cause disability than in adults
  23. Buffalo, NY – October 14, 2009.
    Buffalo Neurologists Investigate Possible New Underlying Cause of MS
    University of Buffalo
    UB Reporter
    Buffalo News
    Channel 4 News
  24. Bologna, Italy, September 8, 2009. 
    Chronic Cerebrospinal Venous Insufficiency (CCSVI) in MS.
  25. Buffalo, NY – August 17, 2009.
    MS Patients Who Smoke Show More Brain Atrophy, More Lesions, than MS Nonsmokers.
  26. Buffalo, NY – March 2, 2009.
    Epstein virus may be associated with progression of MS
  27. Buffalo, NY – April 20, 2008.
    Advanced MRI Studies Provide New Insight on Early Parkinson’s Disease
  28. Buffalo, NY – April 4, 2008.
    MS Affects Different Brain Regions in Men and Women, UB Study Shows
  29. Buffalo, NY – October 13, 2007. Cigarette Smoking May Accelerate Disability in Those with MS.
    University of Buffalo
    Science Daily
  30. Buffalo, NY – September 29, 2007.
    Expanded UB Neuroimaging Analysis Center Unveiled at Buffalo General Hosptial.
  31. Cambridge, MA – September 29, 2006. Avonex®, The #1 Prescribed Multiple Sclerosis (MS) Therapy Worldwide: New MRI Data Presented.
    Investor Village.


  1. ECTRIMS 2016 Robert Zivadinov Interview – Dr. Zivadinov discusses real-world studies and how they add to our understanding of the multiple sclerosis disease course and patient management. September 16, 2016; Excel Centre; London, England.
  2. ECTRIMS 2016 Robert Zivadinov Interview – PROTRACT-Interferon Beta Study PROTRACT is a multi-centre retrospective real-world evidence study on-going in the United States and Canada. It is designed to show safety, efficacy and tolerability of FDA-approved modifying therapies on MS patients.
    September 17, 2016; Excel Centre; London, England.
  3. A new image of multiple sclerosis, Summer 2013 edition of UB Medicine.
  4. Don’t Dismiss CCVSI Yet, Expert Says, 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Americas Committee for Treatment and Research In Multiple Sclerosis (ACTRIMS), Medscape Neurology, June 10, 2013.
  5. UB Studies Link Thalamus Atrophy to MS; Suggest Evaluation Tool, School of Medicine and Biomedical Science, University at Buffalo, June 10, 2013.
  6. New biomarker could be a game changer for multiple sclerosis research, study, DOTmed Daily News, April 24, 2013.
  7. Researchers find link between glandular shrinkage, MS, Medill Reports, Chicago, April 23, 2013.
  8. A sham procedure leads to disappointing MS news, The New York Times, March 20, 2013.
  9. Vein surgery for MS fails in first controlled trial, MedPage Today, March 15, 2013.
  10. CCSVI in multiple sclerosis, a clinical context report. MedPage Today, April 07, 2012.
  11. More than 50  interviews on chronic cerebrospinal venous insufficiency (CCSVI )in the first 6 months of 2010  given to: CTV, CBC, CBS, BBC, French TV, Australian TV, Medscape, NMSS, WSJ, Montreal gazzeta, Globe, Ann Neurol, Mobility Magazine, Politika, Nacional, etc.
    (See relative websites for specific articles)
  12. Study could hold key to MS treatment. Buffalo News, December 20, 2009
  13. MS vein theory creates ‘huge hope’: doctor. CBC, December 15, 2009
  14. Interferon-beta-1a slows down progression of brain atrophy in relapsing-remitting multiple sclerosis by reducing predominantly grey matter atrophy progression. Clinical Impressions 02/2008
  15. Research on the brain. Buffalo Physician Winter issue 2008;4-8.
  16. MS that runs in families appears more severe than non-familial MS. 9/13/07
    MS ToolKit Blog
  17. Kaleida takes stake in neurological facility. Buffalo Business First. 9/28/07
  18. Jacobs Neurological Institute unveils new Neuroimaging Center. The Buffalo News: City & Region. 9/27/07
  19. A Scientist in the US must also be a businessman. National. 9/18/07;275:58-60
  20. Behind the science: Highlighting Buffalo Niagara’s top researchers – Robert Zivadinov, M.D., Ph.D. Bufflink e- newsletter 2004;2(1).